Page last updated: 2024-10-18

dalteparin and Acquired Hyperostosis Syndrome

dalteparin has been researched along with Acquired Hyperostosis Syndrome in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Acquired Hyperostosis Syndrome: Syndrome consisting of SYNOVITIS; ACNE CONGLOBATA; PALMOPLANTAR PUSTULOSIS; HYPEROSTOSIS; and OSTEITIS. The most common site of the disease is the upper anterior chest wall, characterized by predominantly osteosclerotic lesions, hyperostosis, and arthritis of the adjacent joints. The association of sterile inflammatory bone lesions and neutrophilic skin eruptions is indicative of this syndrome.

Research Excerpts

ExcerptRelevanceReference
"Venous thrombosis complicating SAPHO syndrome seems to be uncommon with an unclear pathogenesis (3-9)."1.43Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome. ( Brzosko, M; Przepiera-Będzak, H, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Przepiera-Będzak, H1
Brzosko, M1

Other Studies

1 other study available for dalteparin and Acquired Hyperostosis Syndrome

ArticleYear
Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
    Acta dermatovenerologica Croatica : ADC, 2016, Volume: 24, Issue:4

    Topics: Acquired Hyperostosis Syndrome; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Enoxa

2016